Advertisement
UK markets open in 7 hours 32 minutes
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • CRUDE OIL

    79.04
    +0.04 (+0.05%)
     
  • GOLD FUTURES

    2,331.90
    +20.90 (+0.90%)
     
  • DOW

    37,903.29
    +87.37 (+0.23%)
     
  • Bitcoin GBP

    46,185.43
    -2,114.21 (-4.38%)
     
  • CMC Crypto 200

    1,271.33
    -67.74 (-5.06%)
     
  • NASDAQ Composite

    15,605.48
    -52.34 (-0.33%)
     
  • UK FTSE All Share

    4,418.60
    -11.65 (-0.26%)
     

US STOCKS-Futures little changed on caution ahead of jobs report

* U.S. jobs report to signal stronger growth momentum

* Astrazeneca (NYSE: AZN - news) rejects Pfizer (NYSE: PFE - news) 's raised bid of $106 bln

* Futures: Dow up 3 pts, S&P up 1 pt, Nasdaq up 1 pt

By Angela Moon

NEW YORK (Frankfurt: HX6.F - news) , May 2 (Reuters) - U.S. stock index futures were little changed Friday on caution ahead of the key U.S. nonfarm payrolls report for April.

* The payrolls report, due out at 8:30 a.m. ET (1230 GMT), is expected to show U.S. hiring likely increased at its quickest pace in five months in April, which would bolster hopes of a strong rebound in economic activity in the second quarter.

ADVERTISEMENT

* Employers probably added 210,000 jobs last month after increasing headcount by 192,000 in March, according to a Reuters poll. That would also beat the pace of payrolls gains in the first quarter, of 177,667 jobs per month.

* Data released Thursday showed the number of Americans filing new claims for unemployment benefits unexpectedly rose last week, but the underlying trend continued to point to improving labor market conditions.

* S&P 500 e-mini futures added 1 point and were in line with fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures rose 3 points and Nasdaq 100 futures added 1 point.

* U.S. drugmaker Pfizer Inc 's sweetened 63 billion pound ($106 billion) bid for AstraZeneca Plc was promptly rejected by the British company Friday. Pfizer shares were little changed in premarket trade.

* LinkedIn Corp shares slipped more than 3 percent in premarket trading, a day after the social networking company forecast 2014 revenue below Wall Street's expectations, underscoring concerns about its ability to sustain its rapid growth and helping to drag its shares lower.

* German drugmaker Bayer AG (Milan: BAY.MI - news) is nearing an agreement to buy Merck (Dusseldorf: 6MK.DU - news) & Co Inc's consumer healthcare unit, people familiar with the matter said, in a deal that could value the business at around $14 billion.

* The S&P 500 ended little changed on Thursday as investors paused ahead of Friday's jobs report, though gains in Internet shares helped lift the Nasdaq. (Editing by Bernadette Baum)